Key Points
- Oscar Health director Mario Schlosser sold 34,120 shares on June 2 at an average price of $21.94, for proceeds of about $748,593. The sale was made under a pre-arranged 10b5-1 plan to cover tax withholding tied to equity awards.
- The transaction reduced Schlosser’s holdings to 480,866 shares, a 6.63% decrease in his ownership stake. Other insiders have also sold shares recently, though the article notes these were largely planned transactions.
- Oscar Health has seen a mixed but improving backdrop: the stock has risen near its 52-week high, the company beat Q1 EPS estimates, and several analysts recently upgraded the shares, though the overall consensus rating remains Hold.
Oscar Health, Inc. (NYSE:OSCR - Get Free Report) CAO Victoria Baltrus sold 1,523 shares of the business's stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $21.94, for a total value of $33,414.62. Following the transaction, the chief accounting officer owned 214,589 shares in the company, valued at $4,708,082.66. This represents a 0.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Oscar Health Trading Up 14.8%
Shares of OSCR opened at $23.54 on Friday. Oscar Health, Inc. has a 12-month low of $10.69 and a 12-month high of $25.58. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $7.10 billion, a price-to-earnings ratio of -39.90, a P/E/G ratio of 1.43 and a beta of 2.37. The stock's 50-day moving average price is $18.15 and its 200 day moving average price is $16.00.
Oscar Health (NYSE:OSCR - Get Free Report) last issued its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same period in the previous year, the company posted $0.92 earnings per share. The company's quarterly revenue was up 52.6% compared to the same quarter last year. As a group, research analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current year.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on the company. Robert W. Baird boosted their price target on Oscar Health from $15.00 to $19.00 and gave the company a "neutral" rating in a research note on Thursday, May 7th. Raymond James Financial raised Oscar Health from a "market perform" rating to an "outperform" rating and set a $18.00 price objective on the stock in a report on Thursday, February 12th. UBS Group lifted their price objective on Oscar Health from $15.00 to $20.00 and gave the company a "neutral" rating in a report on Thursday, May 7th. Wells Fargo & Company set a $20.00 price objective on Oscar Health and gave the company an "equal weight" rating in a report on Thursday. Finally, Wolfe Research assumed coverage on Oscar Health in a report on Tuesday, May 5th. They set a "peer perform" rating on the stock. One research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company's stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus price target of $20.22.
View Our Latest Stock Report on Oscar Health
More Oscar Health News
Here are the key news stories impacting Oscar Health this week:
- Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, suggesting the worst of the downside may be behind the stock even though the new $20 target still sits below the current share price. Zacks.com
- Positive Sentiment: A news item that Oscar Health co-founder is shifting into an advisory leadership role appears to be an internal transition rather than a disruptive change, which may be viewed as manageable by investors. Oscar Health Co-Founder Shifts to Advisory Leadership Role
- Neutral Sentiment: Oscar Health reported strong first-quarter EPS of $2.07, beating estimates by a wide margin, though revenue came in below expectations. The earnings beat supports the company’s fundamentals, but the softer revenue print limits the upside reaction.
- Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley, Janet Liang, Adam Mcananey, Director Mario Schlosser, and CAO Victoria Baltrus, sold shares under pre-arranged 10b5-1 plans to cover tax withholding on vested equity awards. Because these were scheduled transactions, they are less alarming than discretionary selling, but the cluster of sales can still pressure sentiment.
- Negative Sentiment: The most notable insider sale was by Director Mario Schlosser, who sold 34,120 shares, adding to the perception that leadership is reducing exposure even if the trade was pre-planned.
Institutional Investors Weigh In On Oscar Health
Institutional investors have recently added to or reduced their stakes in the stock. Quarry LP boosted its holdings in Oscar Health by 439.8% during the third quarter. Quarry LP now owns 1,803 shares of the company's stock valued at $34,000 after purchasing an additional 1,469 shares in the last quarter. Tsfg LLC acquired a new position in shares of Oscar Health in the 3rd quarter worth approximately $38,000. Jones Financial Companies Lllp boosted its holdings in shares of Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company's stock worth $30,000 after acquiring an additional 2,242 shares in the last quarter. Strs Ohio acquired a new position in shares of Oscar Health in the 1st quarter worth approximately $30,000. Finally, Fifth Third Bancorp boosted its holdings in shares of Oscar Health by 148.7% in the 4th quarter. Fifth Third Bancorp now owns 2,363 shares of the company's stock worth $34,000 after acquiring an additional 1,413 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.
About Oscar Health
(
Get Free Report)
Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.
The company's primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
